Related Experiment Videos
Discoid lupus erythematosus masquerading as chronic blepharoconjunctivitis
Nisha Acharya1, Roberto Pineda, Harvey S Uy
1Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, USA.
Ophthalmology
|May 10, 2005
Summary
Discoid lupus erythematosus (DLE) can cause chronic blepharoconjunctivitis. Early detection and treatment with hydroxychloroquine can effectively manage this eyelid condition.
Area of Science:
- Ophthalmology
- Dermatology
- Immunology
Background:
- Discoid lupus erythematosus (DLE) is a chronic autoimmune condition that can affect various parts of the body, including the eyelids.
- Chronic blepharoconjunctivitis can have multiple causes, and DLE is an often-overlooked etiology.
- Prompt diagnosis and treatment are crucial for managing DLE to prevent long-term complications.
Observation:
- A retrospective observational case series reviewed records of 5 patients with biopsy-proven DLE affecting the eyelids.
- Clinical manifestations included meibomian gland dysfunction, blepharitis, chalazia, trichiasis, madarosis, conjunctivitis, chronic eyelid edema, and eyelid plaques.
- Histopathological findings revealed hyperkeratotic epithelium, basal cell layer degeneration, and perivascular lymphocytic infiltrate.
Findings:
- Diagnosis of DLE in these cases was significantly delayed, ranging from 4 months to 25 years.
- All patients with eyelid DLE demonstrated a positive response to systemic hydroxychloroquine therapy.
- The study highlights the treatable nature of DLE presenting as chronic blepharoconjunctivitis.
Implications:
- Increased awareness of DLE as a cause of chronic blepharoconjunctivitis is essential for earlier detection.
- Timely diagnosis and initiation of specific therapies, such as hydroxychloroquine, can lead to better patient outcomes.
- This research underscores the importance of considering autoimmune conditions in the differential diagnosis of persistent eyelid and conjunctival inflammation.